FARZANA RASHID: Open Payments
NPI 1528654696 · NEW SMYRNA BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,991 in 88 payments from 13 companies in 2025. Trend: 2023 $676 · 2024 $1,252 · 2025 $1,991
Food & beverage: $1,991
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $539 |
| Celltrion USA Inc. | 19 | $377 |
| EVOKE PHARMA, INC. | 9 | $230 |
| Janssen Biotech, Inc. | 11 | $178 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $165 |
| Ipsen Biopharmaceuticals, Inc | 4 | $127 |
| Madrigal Pharmaceuticals | 5 | $115 |
| Ardelyx, Inc. | 3 | $64 |
| Novo Nordisk Inc | 2 | $51 |
| Braintree Laboratories, Inc. | 2 | $49 |
Products named: VEGZELMA, CREON, GIMOTI, TREMFYA, IQIRVO, ZYMFENTRA, ENTYVIO, RINVOQ.
Industry payments across FL — which companies pay providers there.
